BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nie LJ, Wang GX, Yang XY, Sun J, Cao YT, Lou Y, Lu YF, Yu JY, Zhou XQ. Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease via peroxisome proliferator-activated receptor alpha pathway activation. World J Gastroenterol 2026; 32(9): 114544 [PMID: 41810443 DOI: 10.3748/wjg.v32.i9.114544]
URL: https://www.wjgnet.com/1007-9327/full/v32/i9/114544.htm
Number Citing Articles
1
Bin Li, Yu-Meng Liu, Rui-Xi Ming, Tian-Ci Tang. Letter to the Editor: Lianhe Xiaozhi ointment for metabolic dysfunction-associated steatotic liver disease - a gut-liver-brain axis perspectiveWorld Journal of Gastroenterology 2026; 32(32): 118636 doi: 10.3748/wjg.118636
2
Yasser Fouad, Ebada M Said, Lubna Kamani, Hisham R El-Khayat. Reviving peroxisome proliferator-activated receptors in fatty liver disease: From herbal formula to nuclear receptor targetingWorld Journal of Gastroenterology 2026; 32(35): 119168 doi: 10.3748/wjg.119168